{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:25:10Z","timestamp":1793823910564,"version":"4.6.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies have shown that tirofiban (a glycoprotein IIb\/IIIa receptor antagonist) is effective in the endovascular treatment of cerebrovascular diseases. However, it has also been reported that tirofiban can cause thrombocytopenia. Here we report a rare case of tirofiban-induced acute profound thrombocytopenia in a patient undergoing endovascular therapy for acute ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>A 39-year-old male patient was sent to the emergency department of our hospital due to a sudden onset of disturbance in consciousness, aphasia and right hemiparesis for 2\u00a0h. Computed tomography angiogram (CTA) revealed an occlusion of the left middle cerebral artery. He was directed into emergency embolectomy with stent implantation under digital subtraction angiography (DSA) guidance. Due to the extensive clot formation during surgery, a bolus of 20\u00a0ml tirofiban was slowly injected through the guiding catheter. Approximately two hours after the infusion, the patient developed acute profound thrombocytopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tirofiban-induced thrombocytopenia after drug infusion may occur acutely and without any bleeding manifestations. There may be a clinical correlation between the loading dose of tirofiban and the occurrence of acute profound thrombocytopenia. Clinicians should maintain high caution for the potential crash of platelet levels when this drug is administered during procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-025-04368-1","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T02:35:40Z","timestamp":1756262140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tirofiban-induced acute profound thrombocytopenia in endovascular therapy for acute ischemic stroke: a rare case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiuling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melysze Deanne","family":"Oorloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Nadella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"4368_CR1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2147\/CIA.S238769","volume":"15","author":"X Huo","year":"2020","unstructured":"Huo X, Yang M, Ma N, et al. Safety and efficacy of Tirofiban during mechanical thrombectomy for stroke patients with preceding intravenous Thrombolysis[J]. Clin Interv Aging. 2020;15:1241\u20138.","journal-title":"Clin Interv Aging"},{"issue":"10","key":"4368_CR2","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20198396","volume":"52","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang QQ, Fu C, et al. Clinical efficacy of tirofiban combined with a solitaire stent in treating acute ischemic stroke. Braz J Med Biol Res. 2019;52(10): e8396.","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"4368_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00270-023-03372-7","volume":"46","author":"R Garayzade","year":"2023","unstructured":"Garayzade R, Berlis A, Schiele S, et al. Comparison of safety and efficacy after emergency stenting in patients exhibiting intracranial atherosclerotic stenosis associated with large-vessel occlusion with and without intravenous infusion of tirofiban. Cardiovasc Intervent Radiol. 2023;46(3):377\u201384.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"4368_CR4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1182\/blood.V100.6.2071","volume":"100","author":"DW Bougie","year":"2002","unstructured":"Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa. Blood. 2002;100(6):2071\u20136.","journal-title":"Blood"},{"issue":"8","key":"4368_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/01.CIR.101.8.938","volume":"101","author":"MB Holmes","year":"2000","unstructured":"Holmes MB, Kabbani S, Watkins MW, et al. Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia[J]. Circulation. 2000;101(8):938\u20139.","journal-title":"Circulation"},{"issue":"5","key":"4368_CR6","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","volume":"96","author":"Effects of platelet","year":"1997","unstructured":"Effects of platelet. Glycoprotein iib\/iiia Blockade with Tirofiban on adverse cardiac events in patients withunstableangina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE investigators. Randomized efficacy study of Tirofiban for outcomes and REstenosis[J]. Circulation. 1997;96(5):1445\u201353.","journal-title":"Circulation"},{"issue":"20","key":"4368_CR7","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1161\/01.CIR.102.20.2466","volume":"102","author":"P Theroux","year":"2000","unstructured":"Theroux P, Alexander JJ, Pharand C, et al. Glycoprotein iib\/iiia receptor Blockade improves outcomes in diabetic patients presenting with unstable angina\/non-ST-elevation myocardial infarction: results from the platelet receptor Inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS) study[J]. Circulation. 2000;102(20):2466\u201372.","journal-title":"Circulation"},{"issue":"18","key":"4368_CR8","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1161\/01.CIR.0000127867.41621.85","volume":"109","author":"PA Merlini","year":"2004","unstructured":"Merlini PA, Rossi M, Menozzi A, et al. Thrombocytopenia caused by Abciximab or Tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation. 2004;109(18):2203\u20136.","journal-title":"Circulation"},{"key":"4368_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.987859","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Xiao Q, Shi Z, et al. Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction. Front Neurol. 2022;13: 987859.","journal-title":"Front Neurol"},{"issue":"9","key":"4368_CR10","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","volume":"42","author":"M Siebler","year":"2011","unstructured":"Siebler M, Hennerici MG, Schneider D, et al. Safety of tirofiban in acute ischemic stroke: the satis trial. Stroke. 2011;42(9):2388\u201392.","journal-title":"Stroke"},{"issue":"1","key":"4368_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11239-006-7789-1","volume":"22","author":"B Demirkan","year":"2006","unstructured":"Demirkan B, Guray Y, Guray U, et al. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: a case report. J Thromb Thrombolysis. 2006;22(1):77\u20138.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"4368_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14504","volume":"9","author":"B Piao","year":"2023","unstructured":"Piao B, Li T, Zhong H, et al. Acute profound thrombocytopenia induced by Tirofiban in stent assisted embolization of intracranial ruptured aneurysm-a rare case report. Heliyon. 2023;9(4): e14504.","journal-title":"Heliyon"},{"issue":"2 Suppl","key":"4368_CR13","doi-asserted-by":"publisher","first-page":"eS495","DOI":"10.1378\/chest.11-2303","volume":"141","author":"LA Linkins","year":"2012","unstructured":"Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians Evidence-Based clinical practice Guidelines[J]. Chest. 2012;141(2 Suppl):eS495\u2013530.","journal-title":"Chest"},{"key":"4368_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-3-14","volume":"3","author":"M Franchini","year":"2005","unstructured":"Franchini M. Heparin-induced thrombocytopenia: an update. Thromb J. 2005;3: 14.","journal-title":"Thromb J"},{"issue":"3","key":"4368_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/000331970505600319","volume":"56","author":"S Patel","year":"2005","unstructured":"Patel S, Patel M, Din I, et al. Profound thrombocytopenia associated with tirofiban: case report and review of literature. Angiology. 2005;56(3):351\u20135.","journal-title":"Angiology"},{"issue":"2","key":"4368_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00392-006-0459-7","volume":"96","author":"SM Said","year":"2007","unstructured":"Said SM, Hahn J, Schleyer E, et al. Glycoprotein IIb\/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol. 2007;96(2):61\u20139.","journal-title":"Clin Res Cardiol"},{"key":"4368_CR17","volume":"8","author":"S Wang","year":"2020","unstructured":"Wang S, Sawalha K, Khan A. An unusual case of drug-induced thrombocytopenia. J Invest Med High Impact Case Rep. 2020;8: 1557554253.","journal-title":"J Invest Med High Impact Case Rep"},{"issue":"12","key":"4368_CR18","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1161\/STROKEAHA.117.019193","volume":"48","author":"W Zhao","year":"2017","unstructured":"Zhao W, Che R, Shang S, et al. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy. Stroke. 2017;48(12):3289\u201394.","journal-title":"Stroke"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04368-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:47:59Z","timestamp":1781610479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4368"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04368-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent obtained from subject of case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}